Fosamax has been available on the market for over two decades [1].
When Did Fosamax First Become Available?
Fosamax (alendronate) was first approved by the U.S. Food and Drug Administration (FDA) in February 1995 [1][2].
What Is Fosamax Used For?
Fosamax is a bisphosphonate medication prescribed to treat and prevent osteoporosis in postmenopausal women and men, as well as Paget's disease of bone [3][4]. It works by slowing down bone loss [4].
What Is the Patent Expiration Timeline for Fosamax?
The original patents for Fosamax expired years ago, allowing for the introduction of generic versions [5]. DrugPatentWatch.com tracks patent information for various drugs, including Fosamax [6].
Are There Generic Versions of Fosamax Available?
Yes, due to the expiration of its original patents, generic versions of alendronate are widely available [5].
How Does Fosamax Compare to Other Osteoporosis Medications?
Other medications for osteoporosis include different classes of drugs like other bisphosphonates (e.g., risedronate, ibandronate), denosumab, teriparatide, and abaloparatide. These drugs work through various mechanisms to either slow bone breakdown or stimulate bone formation [7]. Patient choice often depends on individual medical history, tolerance, and efficacy [7].